Percutaneous irreversible electroporation for the treatment of pancreatic insulinoma - Inria - Institut national de recherche en sciences et technologies du numérique Accéder directement au contenu
Autre Publication Diagnostic and Interventional Imaging Année : 2023

Percutaneous irreversible electroporation for the treatment of pancreatic insulinoma

Résumé

Irreversible electroporation (IRE) is a non-thermal ablative modal- ity that has been used for the treatment of locally advanced pancre- atic ductal adenocarcinoma [1]. However, its use for the treatment of pancreatic neuroendocrine tumors has been rarely reported [2]. We report herein the use of IRE for the treatment of a pancreatic insuli- noma and discuss the potential of this innovative approach.
Fichier non déposé

Dates et versions

hal-04054322 , version 1 (18-04-2023)

Identifiants

Citer

Jean-Pierre Tasu, Mathilde Vionnet, Stéphane Velasco, Luc Lafitte, Clair Poignard. Percutaneous irreversible electroporation for the treatment of pancreatic insulinoma. 2023, ⟨10.1016/j.diii.2023.03.006⟩. ⟨hal-04054322⟩
17 Consultations
3 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More